Case comprehensive cancer center endorses elimination of HPV-related cancers

June 14, 2018, Case Western Reserve University

Nearly 80 million Americans—one out of every four people—are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the U.S.

Case Comprehensive Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.

"I'm really proud of Cleveland's city-wide effort in screening and prevention," said Stanton L. Gerson, MD, Director of the Case Comprehensive Cancer Center. "There's been a longstanding interest in improving the rates of HPV vaccination, and we've negotiated and interacted with our two affiliate hospitals who have both almost tripled their rate of vaccinations of 11-year-old boys and girls for HPV over the past five years."

Case Comprehensive Cancer Center's affiliate hospitals have been heavily involved in on-the-ground efforts to increase HPV vaccinations throughout the city.

"Over the past five years, our community outreach team has been educating parents, grandparents and children on the importance of cancer prevention at back-to-school events sponsored by the City of Cleveland," said Kim Bell, Cleveland Clinic Taussig Cancer Institute Administrator, who is leading efforts to increase uptake in Cleveland. "Providers are improving their conversations and parents are listening to the benefits this vaccine has for their child, and in turn we've seen an increase in vaccination rates and awareness."

NCI-designated cancer centers recognize insufficient vaccination as a public health threat and are calling upon the nations' physicians, parents and young adults to take advantage of this rare opportunity to eliminate several types of cancer in men and women.

"We have worked to greatly improve HPV vaccination rates for the past five years, but we can and need to do better," said Andrew Hertz, MD, Vice President of the UH Rainbow Primary Care Institute, who is also at the forefront of increasing vaccinations in Cleveland. "Preventing cancer through vaccination is an intervention that should be universal. As child advocates, our clinicians and staff educate parents every day of the importance of early HPV vaccination."

HPV vaccination rates remain significantly lower than other recommended adolescent vaccines in the U.S. According to the CDC, less than 50 percent of girls and 38 percent of boys completed the recommended vaccine series. Research shows there are a number of barriers to overcome in order to improve vaccination rates. Physicians need to strongly recommend HPV vaccine to patients, and parents must understand that this vaccine protects against several types of cancer in both men and women. HPV causes multiple cancers including cervical, anal, oropharyngeal (middle throat) and other genital cancers.

HPV experts from the nation's top cancer centers, along with partners from the NCI, CDC, and the American Cancer Society, are holding meetings to discuss a path forward to eliminating cancers caused by HPV, including ways to reduce barriers to vaccination, as well as share education, training and intervention strategies to improve vaccination rates.

This is the third year that all NCI-designated cancer centers have come together to issue a national call to action. All 70 centers unanimously share the goal of sending a powerful message to parents, adolescents and health care providers about the importance of HPV vaccination for the elimination of HPV-related cancers.

Explore further: Parents ranked cancer prevention as number one provider reason for HPV vaccination

Related Stories

Parents ranked cancer prevention as number one provider reason for HPV vaccination

June 14, 2018
Parents ranked cancer prevention as the most compelling reason health care providers can give for recommending the human papillomavirus (HPV) vaccine, according to a survey led by University of North Carolina Lineberger Comprehensive ...

Parents see cancer prevention potential as best reason for HPV vaccination

June 14, 2018
Parents of adolescents believed that the potential to prevent certain types of cancer is the best reason for their children to receive the human papillomavirus (HPV) vaccine, whereas other reasons health care providers often ...

More U.S. teens getting vaccinated against HPV

August 24, 2017
(HealthDay)—Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday.

Not enough kids receiving the recommended three doses of HPV vaccination

February 3, 2016
Most cancers caused by the human papillomavirus (HPV) are preventable with a vaccine. Yet the infection is responsible for 27,000 cancer diagnoses each year in the U.S.

President's panel calls for more girls, boys to get HPV vaccine

February 10, 2014
(HealthDay)—Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President's Cancer Panel reported Monday.

Updated HPV vaccine recommendations endorsed

January 11, 2017
As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has again united with the 68 other National Cancer Institute (NCI)-designated cancer centers in ...

Recommended for you

Non-coding DNA reveals a route by which advanced prostate cancer resists treatment

June 15, 2018
Two research teams converge on epigenetic switches that feed treatment-resistant metastatic prostate tumors. This research highlights the value of exploring gene regulation and large-scale structural changes in the cancer ...

Researchers peer inside cells to spy on cancer's on-off switch

June 15, 2018
Forty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins called PRC2 has become a key target for new cancer-fighting drugs, due to its tendency—when mutated—to bind to and silence ...

PIM-2 protein kinase regulates T-cell activity differently than PIM-1 or PIM-3 isoform

June 15, 2018
The PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity, while PIM-1 and PIM-3 are positive regulators, report Medical University of South Carolina (MUSC) investigators in an article ...

Gene testing could identify men with prostate cancer who may benefit from immunotherapy

June 14, 2018
Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.

Without 'yoga and chardonnay' leukemia stem cells are stressed to death

June 14, 2018
Change is stressful. The change that a healthy blood stem cell undergoes to become a leukemia stem cell (LSC) is no exception—think of healthy blood stem cells as young professionals and the transformation into an LSC as ...

Statins found to enhance efficacy of chemotherapy drug in blood cancers

June 14, 2018
A team of researchers with members affiliated with several institutions in the U.S. has found that some statins could enhance the efficacy of a chemotherapy drug used to fight blood cancers in mouse models. In their paper ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.